Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

From imide to lactam metallo-pyridocarbazoles: distinct scaffolds for the design of selective protein kinase inhibitors.

Pagano N, Wong EY, Breiding T, Liu H, Wilbuer A, Bregman H, Shen Q, Diamond SL, Meggers E.

J Org Chem. 2009 Dec 4;74(23):8997-9009. doi: 10.1021/jo901641k.

2.
3.

Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.

Traxler P, Furet P, Mett H, Buchdunger E, Meyer T, Lydon N.

J Pharm Belg. 1997 Mar-Apr;52(2):88-96. Review.

PMID:
9193132
4.

Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease.

Jain P, Karthikeyan C, Moorthy NS, Waiker DK, Jain AK, Trivedi P.

Curr Drug Targets. 2014 May;15(5):539-50. Review.

PMID:
24568585
5.

Conformationally constrained peptides as protein tyrosine kinase inhibitors.

Tiwari RK, Parang K.

Curr Pharm Des. 2012;18(20):2852-66. Review.

PMID:
22571654
6.

Peptide inhibitors targeting protein kinases.

Eldar-Finkelman H, Eisenstein M.

Curr Pharm Des. 2009;15(21):2463-70. Review.

PMID:
19601843
7.

Clefts as receptor and enzyme analogues.

Rebek J Jr.

Ciba Found Symp. 1991;158:98-109; discussion 109-14, 204-12. Review.

PMID:
1935429

Supplemental Content

Support Center